- Home
- NWTN vs SWKH Comparison
NWTN vs SWKH Comparison
Compare NWTN & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWTN
- SWKH
- Stock Information
- Founded
- NWTN 2016
- SWKH 1996
- Country
- NWTN United Arab Emirates
- SWKH United States
- Employees
- NWTN N/A
- SWKH N/A
- Industry
- NWTN Auto Manufacturing
- SWKH Diversified Financial Services
- Sector
- NWTN Consumer Discretionary
- SWKH Finance
- Exchange
- NWTN Nasdaq
- SWKH Nasdaq
- Market Cap
- NWTN 243.3M
- SWKH 210.8M
- IPO Year
- NWTN N/A
- SWKH 1999
- Fundamental
- Price
- NWTN $1.23
- SWKH $16.10
- Analyst Decision
- NWTN
- SWKH
- Analyst Count
- NWTN 0
- SWKH 0
- Target Price
- NWTN N/A
- SWKH N/A
- AVG Volume (30 Days)
- NWTN 1.2M
- SWKH 7.1K
- Earning Date
- NWTN 01-01-0001
- SWKH 11-14-2024
- Dividend Yield
- NWTN N/A
- SWKH N/A
- EPS Growth
- NWTN N/A
- SWKH N/A
- EPS
- NWTN N/A
- SWKH 0.84
- Revenue
- NWTN $583,000.00
- SWKH $24,725,000.00
- Revenue This Year
- NWTN N/A
- SWKH N/A
- Revenue Next Year
- NWTN N/A
- SWKH $6.17
- P/E Ratio
- NWTN N/A
- SWKH $19.19
- Revenue Growth
- NWTN N/A
- SWKH N/A
- 52 Week Low
- NWTN $0.53
- SWKH $15.77
- 52 Week High
- NWTN $8.74
- SWKH $18.75
- Technical
- Relative Strength Index (RSI)
- NWTN 57.71
- SWKH 37.07
- Support Level
- NWTN $0.99
- SWKH $16.17
- Resistance Level
- NWTN $1.77
- SWKH $17.10
- Average True Range (ATR)
- NWTN 0.20
- SWKH 0.48
- MACD
- NWTN 0.04
- SWKH -0.03
- Stochastic Oscillator
- NWTN 45.67
- SWKH 15.44
About NWTN NWTN Inc.
NWTN Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world.
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.